HomeCompareRUBY vs SCHD

RUBY vs SCHD: Dividend Comparison 2026

RUBY yields 3508.77% · SCHD yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RUBY wins by $2034141393542.05M in total portfolio value
10 years
RUBY
RUBY
● Live price
3508.77%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2034141393542.08M
Annual income
$1,926,153,862,282,748,700.00
Full RUBY calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.46%
Share price
$30.48
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$425.95
Full SCHD calculator →

Portfolio growth — RUBY vs SCHD

📍 RUBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRUBYSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RUBY + SCHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RUBY pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBY
Annual income on $10K today (after 15% tax)
$298,245.61/yr
After 10yr DRIP, annual income (after tax)
$1,637,230,782,940,336,400.00/yr
SCHD
Annual income on $10K today (after 15% tax)
$294.40/yr
After 10yr DRIP, annual income (after tax)
$362.06/yr
At 15% tax rate, RUBY beats the other by $1,637,230,782,940,336,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBY + SCHD for your $10,000?

RUBY: 50%SCHD: 50%
100% SCHD50/50100% RUBY
Portfolio after 10yr
$1017070696771.06M
Annual income
$963,076,931,141,374,600.00/yr
Blended yield
94.69%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBY buys
0
SCHD buys
3
PoliticianChamberTickerTypeAmountDate
Virginia Foxx🏢 House$SCHD▼ Sell$50,001 - $100,0002023-03-08
Steve Cohen🏢 House$SCHD▲ Buy$50,001 - $100,0002022-07-29
Hakeem S. Jeffries🏢 House$SCHD▲ Buy$15,001 - $50,0002021-04-12
Mikie Sherrill🏢 House$SCHD▲ Buy$100,001 - $250,0002020-02-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRUBYSCHD
Forward yield3508.77%3.46%
Annual dividend / share$2.00$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2034141393542.08M$29.0K
Annual income after 10y$1,926,153,862,282,748,700.00$425.95
Total dividends collected$2026733119198.63M$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RUBY vs SCHD ($10,000, DRIP)

YearRUBY PortfolioRUBY Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$361,577$350,877.19$11,226$346.36+$350.4KRUBY
2$12,243,821$11,856,933.69$12,572$357.38+$12.23MRUBY
3$388,336,948$375,236,059.53$14,046$367.84+$388.32MRUBY
4$11,538,279,357$11,122,758,822.00$15,660$377.73+$11538.26MRUBY
5$321,205,540,543$308,859,581,631.20$17,425$387.07+$321205.52MRUBY
6$8,379,307,864,544$8,035,617,936,162.96$19,354$395.86+$8379307.85MRUBY
7$204,877,671,222,196$195,911,811,807,134.25$21,461$404.13+$204877671.20MRUBY
8$4,695,974,086,156,479$4,476,754,977,948,728.50$23,762$411.89+$4695974086.13MRUBY
9$100,922,926,410,592,910$95,898,234,138,405,470.00$26,272$419.15+$100922926410.57MRUBY
10$2,034,141,393,542,082,800$1,926,153,862,282,748,700.00$29,010$425.95+$2034141393542.05MRUBY

RUBY vs SCHD: Complete Analysis 2026

RUBYStock

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Full RUBY Calculator →

SCHDETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this RUBY vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBY vs JEPIRUBY vs ORUBY vs KORUBY vs MAINRUBY vs VYMRUBY vs DGRORUBY vs VIGRUBY vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.